Go Pro

Sareum (SAR) Competitors

Sareum logo
GBX 23.61 +0.61 (+2.65%)
As of 03:23 AM Eastern

SAR vs. IGR, EVG, BTA, CIF, and EFR

Should you buy Sareum stock or one of its competitors? MarketBeat compares Sareum with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sareum include IG Design Group (IGR), Evgen Pharma (EVG), BlackRock Long-Term Municipal Advantage Trust’s (BTA), Carador Income Fund (CIF), and EF Realisation (EFR). These companies are all part of the "diversified financial services" industry.

How does Sareum compare to IG Design Group?

IG Design Group (LON:IGR) and Sareum (LON:SAR) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

IG Design Group currently has a consensus price target of GBX 150, indicating a potential upside of 43.54%. Given IG Design Group's stronger consensus rating and higher possible upside, equities analysts plainly believe IG Design Group is more favorable than Sareum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IG Design Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Sareum
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

IG Design Group has higher revenue and earnings than Sareum. Sareum is trading at a lower price-to-earnings ratio than IG Design Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IG Design Group£217.87M0.45£29.18M-£117.80N/A
SareumN/AN/A-£5.28M-£3.90N/A

IG Design Group has a beta of 0.748, meaning that its share price is 25% less volatile than the broader market. Comparatively, Sareum has a beta of -1.08, meaning that its share price is 208% less volatile than the broader market.

In the previous week, IG Design Group and IG Design Group both had 1 articles in the media. IG Design Group's average media sentiment score of 0.00 equaled Sareum'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IG Design Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Sareum
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

19.4% of IG Design Group shares are held by institutional investors. 21.4% of IG Design Group shares are held by company insiders. Comparatively, 35.7% of Sareum shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Sareum has a net margin of 0.00% compared to IG Design Group's net margin of -1.00%. IG Design Group's return on equity of -2.17% beat Sareum's return on equity.

Company Net Margins Return on Equity Return on Assets
IG Design Group-1.00% -2.17% 2.85%
Sareum N/A -284.01%-113.80%

Summary

IG Design Group beats Sareum on 10 of the 13 factors compared between the two stocks.

How does Sareum compare to Evgen Pharma?

Evgen Pharma (LON:EVG) and Sareum (LON:SAR) are both small-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, profitability, earnings, media sentiment, analyst recommendations and risk.

Evgen Pharma has a beta of 1.44, suggesting that its stock price is 44% more volatile than the broader market. Comparatively, Sareum has a beta of -1.08, suggesting that its stock price is 208% less volatile than the broader market.

Sareum is trading at a lower price-to-earnings ratio than Evgen Pharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evgen PharmaN/AN/A-£3.35M-£0.01N/A
SareumN/AN/A-£5.28M-£3.90N/A

Evgen Pharma's return on equity of -60.57% beat Sareum's return on equity.

Company Net Margins Return on Equity Return on Assets
Evgen PharmaN/A -60.57% -45.52%
Sareum N/A -284.01%-113.80%

27.8% of Evgen Pharma shares are held by institutional investors. 32.4% of Evgen Pharma shares are held by company insiders. Comparatively, 35.7% of Sareum shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Sareum had 1 more articles in the media than Evgen Pharma. MarketBeat recorded 1 mentions for Sareum and 0 mentions for Evgen Pharma. Evgen Pharma's average media sentiment score of 0.00 equaled Sareum'saverage media sentiment score.

Company Overall Sentiment
Evgen Pharma Neutral
Sareum Neutral

Summary

Evgen Pharma beats Sareum on 6 of the 9 factors compared between the two stocks.

How does Sareum compare to BlackRock Long-Term Municipal Advantage Trust’s?

Sareum (LON:SAR) and BlackRock Long-Term Municipal Advantage Trust’s (LON:BTA) are both finance companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

BlackRock Long-Term Municipal Advantage Trust’s' return on equity of 0.00% beat Sareum's return on equity.

Company Net Margins Return on Equity Return on Assets
SareumN/A -284.01% -113.80%
BlackRock Long-Term Municipal Advantage Trust’s N/A N/A N/A

BlackRock Long-Term Municipal Advantage Trust’s has a consensus price target of GBX 220, suggesting a potential upside of 0.00%. Given BlackRock Long-Term Municipal Advantage Trust’s' stronger consensus rating and higher possible upside, analysts plainly believe BlackRock Long-Term Municipal Advantage Trust’s is more favorable than Sareum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sareum
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
BlackRock Long-Term Municipal Advantage Trust’s
3 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.80

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SareumN/AN/A-£5.28M-£3.90N/A
BlackRock Long-Term Municipal Advantage Trust’sN/AN/AN/AN/AN/A

In the previous week, BlackRock Long-Term Municipal Advantage Trust’s had 1 more articles in the media than Sareum. MarketBeat recorded 2 mentions for BlackRock Long-Term Municipal Advantage Trust’s and 1 mentions for Sareum. Sareum's average media sentiment score of 0.00 beat BlackRock Long-Term Municipal Advantage Trust’s' score of -1.00 indicating that Sareum is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sareum
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BlackRock Long-Term Municipal Advantage Trust’s
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative

Summary

BlackRock Long-Term Municipal Advantage Trust’s beats Sareum on 6 of the 7 factors compared between the two stocks.

How does Sareum compare to Carador Income Fund?

Carador Income Fund (LON:CIF) and Sareum (LON:SAR) are both finance companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, profitability and institutional ownership.

Carador Income Fund's return on equity of 0.00% beat Sareum's return on equity.

Company Net Margins Return on Equity Return on Assets
Carador Income FundN/A N/A N/A
Sareum N/A -284.01%-113.80%

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Carador Income FundN/AN/AN/AN/AN/A
SareumN/AN/A-£5.28M-£3.90N/A

In the previous week, Sareum had 1 more articles in the media than Carador Income Fund. MarketBeat recorded 1 mentions for Sareum and 0 mentions for Carador Income Fund. Carador Income Fund's average media sentiment score of 0.00 equaled Sareum'saverage media sentiment score.

Company Overall Sentiment
Carador Income Fund Neutral
Sareum Neutral

Summary

Carador Income Fund beats Sareum on 2 of the 3 factors compared between the two stocks.

How does Sareum compare to EF Realisation?

EF Realisation (LON:EFR) and Sareum (LON:SAR) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends, media sentiment and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EF RealisationN/AN/AN/AN/AN/A
SareumN/AN/A-£5.28M-£3.90N/A

In the previous week, Sareum had 1 more articles in the media than EF Realisation. MarketBeat recorded 1 mentions for Sareum and 0 mentions for EF Realisation. EF Realisation's average media sentiment score of 0.00 equaled Sareum'saverage media sentiment score.

Company Overall Sentiment
EF Realisation Neutral
Sareum Neutral

EF Realisation's return on equity of 0.00% beat Sareum's return on equity.

Company Net Margins Return on Equity Return on Assets
EF RealisationN/A N/A N/A
Sareum N/A -284.01%-113.80%

Summary

EF Realisation beats Sareum on 2 of the 3 factors compared between the two stocks.

Get Sareum News Delivered to You Automatically

Sign up to receive the latest news and ratings for SAR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SAR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SAR vs. The Competition

MetricSareumFinancial Services IndustryFinance SectorLON Exchange
Market Cap£32.56M£27.34B£14.05B£2.96B
Dividend Yield1.10%5.79%5.92%6.13%
P/E Ratio-6.0320.2728.97368.69
Price / SalesN/A389.11474.3383,704.63
Price / Cash11.32153.9538.6127.89
Price / Book9.003.383.737.07
Net Income-£5.28M£1.09B£1.31B£5.89B
7 Day Performance9.30%2.06%1.46%0.59%
1 Month Performance15.47%3.25%1.29%0.25%
1 Year Performance46.78%-9.10%13.60%74.26%

Sareum Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SAR
Sareum
N/AGBX 23.61
+2.7%
N/A+42.4%£32.72MN/AN/A3,211
IGR
IG Design Group
2.8072 of 5 stars
GBX 106
+4.4%
GBX 150
+41.5%
+68.5%£94.08M£217.87MN/A3,092
EVG
Evgen Pharma
N/AN/AN/AN/A£3.42MN/AN/A10
BTA
BlackRock Long-Term Municipal Advantage Trust’s
N/AN/AGBX 215
+∞
N/A£0.00N/AN/AN/A
CIF
Carador Income Fund
N/AN/AN/AN/A£0.00N/AN/AN/A

Related Companies and Tools


This page (LON:SAR) was last updated on 8/5/2026 by MarketBeat.com Staff.
From Our Partners